You searched for: cancer
1 to 3 of 3 results
Show
results per page
Matched phrases in profile:
Primarily endometrial cancer… Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer… Identifying the regulatory targets of common endometrial cancer risk variants… We and our international Endometrial Cancer Association Consortium collaborators have identified… Gynaecological cancer genetics… -enzyme fusion proteins for cancer therapy. He returned to New Zealand to carry out his PhD research… Excessive exposure to estrogen is a well-established risk factor for endometrial cancer (EC…
After completing his BSc and MSc (Hons) at the University of Canterbury (NZ), Dylan worked for five years as a Research Scientist at Antisoma Research Limited (London, UK), developing antibody-enzyme fusion proteins for cancer therapy. He returned to New Zealand to carry out his PhD research into an …
Large numbers of germline genetic variants have been found to associate with disease. A major roadblock in our understanding of how genetics contribute to disease has been a lack of knowledge of the molecular effects of variants. Thus, the aim of my research program is to use genetic analyses to ass …
Matched phrases in profile:
modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank… Cancer genetics… Barbour. Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the… set of 89 esophageal cancer samples. The most hypermethylated tumors showed worse patient survival.…
Dr Sandra Brosda is a Research Fellow within the Surgical Oncology group led by Professor Andrew Barbour.
Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the University of Queensland in November 2020. Her research focused on biomarker discovery and intra-tumour heterogeneity …
Matched phrases in profile:
Cancer is caused by the hyperactivity of genes that are difficult to drug. Utilising the unique… Long noncoding RNAs and the genetics of cancer… Targeting liver cancer with mRNA therapies… infectious diseases and cancer. mRNA-based gene therapies have the potential to alleviate a myriad of… HERA Grant, a Cancer Australia Grant (2021), Mater Foundation seeding grant (2019), a UQ ECR grant… Breast cancer risk is strongly associated with an intergenic region on 11q13. We have previously…
Dr Seth Cheetham is an ARC Discovery Early Career Award Fellow and group leader at the Australian Institute for Bioengineering and Nanotechnology. He is also the Deputy Director of the BASE facility, Australia's leading mRNA manufacturing hub. He completed his PhD at the University of Cambridge, sup …
1 to 3 of 3 results